首页> Annals of medicine> Prognostic factors and an innovative nomogram model for patients with hepatocellular carcinoma treated with postoperative adjuvant transarterial chemoembolization.

Prognostic factors and an innovative nomogram model for patients with hepatocellular carcinoma treated with postoperative adjuvant transarterial chemoembolization.

导出 OA

翻译打印收藏纠错

第一作者： Jing-Xuan,Xu

第一单位： Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.;Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, Guangxi, China.

作者： Jing-Xuan,Xu ^[1] ; Shui-Ling,Qin ^[1] ; Hao-Wen,Wei ^[1] ; Yuan-Yuan,Chen ^[2] ; Yu-Chong,Peng ^[3] ; Lu-Nan,Qi ^[4]

作者单位： Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.;Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, Guangxi, China. ^[1] Department of Ultrasound, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China. ^[2] Department of General Surgery, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, Chongqing, China. ^[3] Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.;Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, Guangxi, China.;Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, Guangxi, China. ^[4]

关键词 Hepatocellular carcinoma (HCC)PA-TACE-insensitivity individualized prediction nomogram post-operative adjuvant transcatheter arterial chemoembolization (PA-TACE)